Андрология и генитальная хирургия. 2023; 24: 48-56
Исторические и современные взгляды на проблему простатолитиаза
https://doi.org/10.17650/2070-9781-2023-24-1-48-56Аннотация
обзоре литературы представлены данные об истории изучения, развития методов диагностики и лечения простатолитиаза и основные сведения о наиболее эффективных методах лечения данной урологической нозологии. Простатолитиаз – одно из распространенных заболеваний предстательной железы, при котором в связи с различными этиологическими факторами камни образуются в паренхиме предстательной железы. Из-за отсутствия единого алгоритма диагностики нет точной эпидемиологической информации о распространенности камней предстательной железы. По данным разных авторов, этот показатель составляет от 7,35 до 88,6 %. В зависимости от расположения камни предстательной железы подразделяют на эндогенные, экзогенные и смешанные. Бессимптомное течение, полиэтиологический патогенез, частые рецидивы воспалительного процесса в предстательной железе с последующим появлением симптомов в нижних мочевыводящих путях, склероз предстательной железы и шейки мочевого пузыря обусловливают чрезвычайно важную роль данной патологии. Простатолитиаз из-за особенностей клинического течения остается одной из самых малоизученных проблем у мужчин в активном трудоспособном возрасте, а также у пожилых мужчин.
Список литературы
1. Fox M. The natural history and significance of stone formation in the prostate gland. J Urol 1963;89(5):716–27. DOI: 10.1016/s0022-5347(17)64633-0
2. Thomas B.A., Robert J.T. Prostatic calculi. J Urol (Baltimore) 1927;18(5):470–93.
3. Cao J.-J., Huang W., Wu H.-S. et al. Prostatic calculi: do they matter? Sex Med Rev 2018;6(3):482–91. DOI: 10.1016/j.sxmr.2017.10.003
4. Fox M. The association of stones in the upper urinary tract with prostatic calculi. Br J Urol 1960;32(4):458–63. DOI: 10.1111/j.1464-410x.1960.tb11570.x
5. Sоndergaard G., Vetner M., Christensen P.O. Prostatic calculi. Acta Pathol Microbiol Immunol Scand A 1987;95(3):141–5. DOI: 10.1111/j.1699-0463.1987.tb00021_95a.x
6. Geramoutsos I., Gyftopoulos K., Perimenis P. et al. Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 2004;45(3):333–7; discussion 337–8. DOI: 10.1016/j.eururo.2003.09.020
7. O’Neill A., Lyons C.A., Jain S. et al. EP-2110: A study of prostatic calculi: in patients receiving radical radiotherapy for prostate cancer. Radiother Oncol 2016;119:S992. DOI: 10.1016/S0167-8140(16)33361-8
8. Suh J.H., Gardner J.M., Kee K.H. et al. Calcifications in prostate and ejaculatory system: a study on 298 consecutive whole mount sections of prostate from radical prostatectomy or cystoprostatectomy specimens. Ann Diagn Pathol 2008;12(3):165–70. DOI: 10.1016/j.anndiagpath.2007.07.001
9. Tang Z., Wu X.-M., Wei Q., Wu L.-N. The prevalence and risk factors of prostatic calcification: an analysis of 68 705 subjects. Asian J Androl 2018;20(4):417–9. DOI: 10.4103/aja.aja_41_17
10. Meng J., Zhang M., Guan S.-Y. et al. The prevalence and risk factors of prostatic calculi in Han Chinese: a cross-sectional study based on health examinations. Aging Male 2020;23(5):887–92. DOI: 10.1080/13685538.2019.1620203
11. Klimas R., Bennett B., Gardner W.A. Jr. Prostatic calculi: a review. Prostate 1985;7(1):91–6. DOI: 10.1002/pros.2990070110
12. Мохаммед А.К.Ш. Камни предстательной железы (этиология, клиника, диагностика и лечение). Автореф. дис. … канд. мед. наук. М., 1989. 24 с.
13. Пасечников С.П., Возианов С.А., Лесовой В.Н. и др. Урология: учебник для студ. высших мед. учебн. заведений. Под ред. С.П. Пасечникова. Пер. с укр. изд. Изд. 2. Винница: Нова Книга, 2015. 456 с.
14. Hyun J.S. Clinical significance of prostatic calculi: a review. World J Mens Health 2018;36(1):15–21. DOI: 10.5534/wjmh.17018
15. Leader A.J.,Queen D.M. Prostatic calculous disease. J Urol 1958;80(2):142–6. DOI: 10.1016/s0022-5347(17)66149-4
16. Park B., Choo S.H. The burden of prostatic calculi is more important than the presence. Asian J Androl 2017;19(4):482–5. DOI: 10.4103/1008-682X.181193
17. Афанасьев Ю.И., Юрина Н.А., Котовский Е.Ф. и др. Гистология, эмбриология, цитология: учебник. Под ред. Ю.И. Афанасьева, Н.А. Юриной. 6-е изд., перераб. и дополн. М.: ГЭОТАРМедиа, 2012. 800 с.
18. Lee S.E., Ku J.H., Park H.K. et al. Prostatic calculi do not influence the level of serum prostate specific antigen in men without clinically detectable prostate cancer or prostatitis. J Urol 2003;170(3):745–8. DOI: 10.1097/01.ju.0000081650.23715.4c
19. Струков А.И., Серов В.В. Патологическая анатомия: учебник. 4-е изд., стереотипное. M.: Медицина, 1995. 88 с.
20. Song W., Zukor H., Liberman A. et al. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol 2014;254:78–89. DOI: 10.1016/j.expneurol.2014.01.006
21. Eikelenboom P., Veerhuis R., Scheper W. et al. The significance of neuroinflammation in understanding Alzheimer’s disease. J Neural Transm (Vienna) 2006;113(11):1685–95. DOI: 10.1007/s00702-006-0575-6
22. Singhrao S.K., Neal J.W., Newman G.R. Corpora amylacea could be an indicator of neurodegeneration. Neuropathol Appl Neurobiol 1993;19(3):269–76. DOI: 10.1111/j.1365-2990.1993.tb00437.x
23. Chung M.H., Horoupian D.S. Corpora amylacea: a marker for mesial temporal sclerosis. J Neuropathol Exp Neurol 1996;55(4):403–8.
24. Cissé S., Perry G., Lacoste-Royal G. et al. Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer’s disease brains. Acta Neuropathol 1993;85(3):233–40. DOI: 10.1007/BF00227716
25. Hoyaux D., Decaestecker C., Heizmann C.W. et al. S100 proteins in Corpora Amylacea from normal human brain. Brain Res 2000;867(1–2):280–8. DOI: 10.1016/s0006-8993(00)02393-3
26. Botez G., Rami A. Immunoreactivity for Bcl-2 and C-Jun/AP1 in hippocampal corpora amylacea after ischaemia in humans. Neuropathol Appl Neurobiol 2001;27(6):474–80. DOI: 10.1046/j.1365-2990.2001.00362.x
27. Комяков Б.К. Урология: учебник. 2-е изд., перераб. и дополн. М.: ГЭОТАР-Медиа, 2018. 480 с.
28. Комяков Б.К., Назаров Т.Х., Ризоев Х.Х. Хронический обструктивный простатит: монография. Изд. 2-е, доп. СПб: Русская коллекция, 2016. 111 с.
29. Назаров Т.Н., Михайличенко В.В. Эффективность применения препарата таденан при хроническом простатите, осложненном бесплодием. Урология 2008;(4):40–3.
30. Назаров Т.Н., Новиков А.И, Михайличенко В.В., Ризоев Х.Х. и др. Применение димексид-ферментной смеси в комплексной терапии хронического бактериального простатита у мужчин с нарушением фертильности. Андрология и генитальная хирургия 2011;4:54–7.
31. Bartoletti R., Cai T., Nesi G. et al. The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study. World J Urol 2014;32(3):737–42. DOI: 10.1007/s00345-013-1145-9
32. Koseoglu H., Aslan G., Sen B.H. et al. [Prostatic calculi: silent stones (In Spanish)]. Actas Urol Esp 2010;34(6);555–9. DOI: 10.1016/S2173-5786(10)70129-3
33. Dessombz A., Méria P., Bazin D., Daudon M. Prostatic stones: evidence of a specific chemistry related to infection and presence of bacterial imprints. PLoS One 2012;7(12):e51691. DOI: 10.1371/journal.pone.0051691
34. Тиктинский О.Л., Тиктинский Н.О. Инфекционный простатит и эпидемиология. Материалы пленума правления Российского общества урологов. М., 2004. С. 369.
35. Ткачук В.Н. Хронический простатит. М.: Медицина для всех, 2006. 112 с.
36. Sutor D.J., Wooley S.E. The crystalline composition of prostatic calculi. Br J Urol 1974;46(5):533–5. DOI: 10.1111/j.1464-410x.1974.tb03852.x
37. Torres Ramirez C., Aguilar Ruiz J., Zuluaga Gomez A. et al. A crystallographic study of prostatic calculi. J Urol 1980;124(6):840–3. DOI: 10.1016/s0022-5347(17)55691-8
38. Cristol D.S., Emmett J.L. The incidence of coincident prostatic calculi, prostatic hyperplasia and carcinoma of the prostate gland. JAMA 1944;124(10):646. DOI: 10.1001/jama.1944.62850100004008a
39. Griffiths G.J., Clements R., Jones D.R. et al. The ultrasound appearances of prostatic cancer with histological correlation. Clin Radiol 1987;38(3):219–27. DOI: 10.1016/s0009-9260(87)80048-x
40. Smolski M., Turo R., Whiteside S. et al. Prevalence of prostatic calcification subtypes and association with prostate cancer. Urology 2015;85(1):178–81. DOI: 10.1016/j.urology.2014.09.026
41. Dell Atti L., Galosi A.B., Ippolito C. Prostatic calculi detected in peripheral zone of the gland during a transrectal ultrasound biopsy can be significant predictors of prostate cancer. Arch Ital Urol Androl 2016;88(4):304–7. DOI: 10.4081/aiua.2016.4.304
42. Kim S.H., Jung K.I., Koh J.S. et al. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi? Urol Int 2013;90(2):144–9. DOI: 10.1159/000342643
43. Harada K., Igari D., Tanahashi Y. Gray scale transrectal ultransonography of the prostate. J Clin Ultrasound 1979;7(1):45–9. DOI: 10.1002/jcu.1870070113
44. Гусейнов Ф.И.О., Камни предстательной железы у больных аденомой и раком простаты. Дис. … канд. мед. наук. М., 2013. 123 с.
45. Epstein J.I. Prostate biopsy interpretation, 2nd edn. Philadelphia: Lippincott Raven, 1995. 30 p.
46. Bai Y., Wang M.-Y., Han Y.-H. et al. Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification. PLoS One 2013;8(1):e53237. DOI: 10.1371/journal.pone.0053237
47. Sfanos K.S., Wilson B.A., De Marzo A.M., Isaacs W.B. Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci U S A 2009;106(9):3443–8. DOI: 10.1073/pnas.0810473106
48. Yanamandra K., Alexeyev O., Zamotin V. et al. Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS One 2009;4(5):e5562. DoI: 10.1371/journal. pone.0005562
49. Horita S., Nitta K., Ozasa H. et al. Localization of beta-2-microglobulin in prostatic corpora amylacea of prostatic hypertrophy patients. Nephron 1996;72(4):730–1. DOI: 10.1159/000188981
50. Vilches J., Lopez A., De Palacio L. et al. SEM and X-ray microanalysis of human prostatic calculi. J Urol 1982;127(2):371–3. DOI: 1016/s0022-5347(17)53784-2
51. Najoui M., Qarro A., Ammani A., Alami M. Giant prostatic calculi. Pan Afr Med J 2013;14:69. DOI: 10.11604/pamj.2013.14.69.2376
52. Kapogiannis F., Fasoulakis K., Fragkoulis C. et al. Total osseous calcification of the prostate gland. Cureus 2020;12(7):e9239. DOI: 10.7759/cureus.9239
53. Zhao W.P., Li Y.T., Chen J. et al. Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis. Asian J Androl 2012;14(5):715–9. DOI: 10.1038/aja.2012.40
54. Cha W.H., Kim K.H., Seo Y.J. The effect of periurethral prostatic calculi on lower urinary tract symptoms in benign prostatic hyperplasia. Korean J Urol 2008;49(3):237–41. DOI: 10.4111/kju.2008.49.3.237
55. Shoskes D.A., Lee C.T., Murphy D. et al. Incidence and significance of prostatic stones in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2007;70(2):235–8. DOI: 10.1016/j.urology.2007.04.008
56. Trinchieri A., Perletti G., Magri V. Prostatic calcifications and symptoms of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol Suppl 2010;9:137–8.
57. Kuei C.H., Liao C.H., Chiang B.J. Significant intravesical prostatic protrusion and prostatic calcification predict unfavorable outcomes of medical treatment for male lower urinary tract symptoms. Urol Sci 2016;27(1):13–6. DOI: 10.1016/j.urols.2015.01.003
58. Jeon H.J., Chung H.C., Song J.M. Effects of residual prostatic calculi on lower urinary tract symptoms after transurethral resection of prostate. Korean J Urol 2005;46:569–73.
Andrology and Genital Surgery. 2023; 24: 48-56
Historical and modern views on the problem of prostatolithiasis
https://doi.org/10.17650/2070-9781-2023-24-1-48-56Abstract
In the literature review the authors present data on the history of the development of diagnostics and treatment of patients with prostatolithiasis and basic information about the most effective methods of treatment of this urological nosology. Prostatolithiasis is one of the most common diseases of the prostate in which, due to various etiological factors, stones are formed in the parenchyma of the prostate gland. Due to the lack of a single diagnostic algorithm, there is no accurate epidemiological information on the prevalence of prostate stones. According to various authors, this figure starts from 7.35 % and reaches 88.6 %. Depending on the localization, prostate stones are divided into endogenous, exogenous and mixed. Asymptomatic course, polyetiological pathogenesis, frequent recurrences of the inflammatory process in the prostate gland with the subsequent appearance of symptoms of the lower urinary tract, sclerosis of the prostate and bladder neck determine the extremely important role of this pathology. Prostatolithiasis, due to its specific clinical course, continues to be one of the most poorly studied problems in men of active working age, as well as in elderly men.
References
1. Fox M. The natural history and significance of stone formation in the prostate gland. J Urol 1963;89(5):716–27. DOI: 10.1016/s0022-5347(17)64633-0
2. Thomas B.A., Robert J.T. Prostatic calculi. J Urol (Baltimore) 1927;18(5):470–93.
3. Cao J.-J., Huang W., Wu H.-S. et al. Prostatic calculi: do they matter? Sex Med Rev 2018;6(3):482–91. DOI: 10.1016/j.sxmr.2017.10.003
4. Fox M. The association of stones in the upper urinary tract with prostatic calculi. Br J Urol 1960;32(4):458–63. DOI: 10.1111/j.1464-410x.1960.tb11570.x
5. Sondergaard G., Vetner M., Christensen P.O. Prostatic calculi. Acta Pathol Microbiol Immunol Scand A 1987;95(3):141–5. DOI: 10.1111/j.1699-0463.1987.tb00021_95a.x
6. Geramoutsos I., Gyftopoulos K., Perimenis P. et al. Clinical correlation of prostatic lithiasis with chronic pelvic pain syndromes in young adults. Eur Urol 2004;45(3):333–7; discussion 337–8. DOI: 10.1016/j.eururo.2003.09.020
7. O’Neill A., Lyons C.A., Jain S. et al. EP-2110: A study of prostatic calculi: in patients receiving radical radiotherapy for prostate cancer. Radiother Oncol 2016;119:S992. DOI: 10.1016/S0167-8140(16)33361-8
8. Suh J.H., Gardner J.M., Kee K.H. et al. Calcifications in prostate and ejaculatory system: a study on 298 consecutive whole mount sections of prostate from radical prostatectomy or cystoprostatectomy specimens. Ann Diagn Pathol 2008;12(3):165–70. DOI: 10.1016/j.anndiagpath.2007.07.001
9. Tang Z., Wu X.-M., Wei Q., Wu L.-N. The prevalence and risk factors of prostatic calcification: an analysis of 68 705 subjects. Asian J Androl 2018;20(4):417–9. DOI: 10.4103/aja.aja_41_17
10. Meng J., Zhang M., Guan S.-Y. et al. The prevalence and risk factors of prostatic calculi in Han Chinese: a cross-sectional study based on health examinations. Aging Male 2020;23(5):887–92. DOI: 10.1080/13685538.2019.1620203
11. Klimas R., Bennett B., Gardner W.A. Jr. Prostatic calculi: a review. Prostate 1985;7(1):91–6. DOI: 10.1002/pros.2990070110
12. Mokhammed A.K.Sh. Kamni predstatel'noi zhelezy (etiologiya, klinika, diagnostika i lechenie). Avtoref. dis. … kand. med. nauk. M., 1989. 24 s.
13. Pasechnikov S.P., Vozianov S.A., Lesovoi V.N. i dr. Urologiya: uchebnik dlya stud. vysshikh med. uchebn. zavedenii. Pod red. S.P. Pasechnikova. Per. s ukr. izd. Izd. 2. Vinnitsa: Nova Kniga, 2015. 456 s.
14. Hyun J.S. Clinical significance of prostatic calculi: a review. World J Mens Health 2018;36(1):15–21. DOI: 10.5534/wjmh.17018
15. Leader A.J.,Queen D.M. Prostatic calculous disease. J Urol 1958;80(2):142–6. DOI: 10.1016/s0022-5347(17)66149-4
16. Park B., Choo S.H. The burden of prostatic calculi is more important than the presence. Asian J Androl 2017;19(4):482–5. DOI: 10.4103/1008-682X.181193
17. Afanas'ev Yu.I., Yurina N.A., Kotovskii E.F. i dr. Gistologiya, embriologiya, tsitologiya: uchebnik. Pod red. Yu.I. Afanas'eva, N.A. Yurinoi. 6-e izd., pererab. i dopoln. M.: GEOTARMedia, 2012. 800 s.
18. Lee S.E., Ku J.H., Park H.K. et al. Prostatic calculi do not influence the level of serum prostate specific antigen in men without clinically detectable prostate cancer or prostatitis. J Urol 2003;170(3):745–8. DOI: 10.1097/01.ju.0000081650.23715.4c
19. Strukov A.I., Serov V.V. Patologicheskaya anatomiya: uchebnik. 4-e izd., stereotipnoe. M.: Meditsina, 1995. 88 s.
20. Song W., Zukor H., Liberman A. et al. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol 2014;254:78–89. DOI: 10.1016/j.expneurol.2014.01.006
21. Eikelenboom P., Veerhuis R., Scheper W. et al. The significance of neuroinflammation in understanding Alzheimer’s disease. J Neural Transm (Vienna) 2006;113(11):1685–95. DOI: 10.1007/s00702-006-0575-6
22. Singhrao S.K., Neal J.W., Newman G.R. Corpora amylacea could be an indicator of neurodegeneration. Neuropathol Appl Neurobiol 1993;19(3):269–76. DOI: 10.1111/j.1365-2990.1993.tb00437.x
23. Chung M.H., Horoupian D.S. Corpora amylacea: a marker for mesial temporal sclerosis. J Neuropathol Exp Neurol 1996;55(4):403–8.
24. Cissé S., Perry G., Lacoste-Royal G. et al. Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer’s disease brains. Acta Neuropathol 1993;85(3):233–40. DOI: 10.1007/BF00227716
25. Hoyaux D., Decaestecker C., Heizmann C.W. et al. S100 proteins in Corpora Amylacea from normal human brain. Brain Res 2000;867(1–2):280–8. DOI: 10.1016/s0006-8993(00)02393-3
26. Botez G., Rami A. Immunoreactivity for Bcl-2 and C-Jun/AP1 in hippocampal corpora amylacea after ischaemia in humans. Neuropathol Appl Neurobiol 2001;27(6):474–80. DOI: 10.1046/j.1365-2990.2001.00362.x
27. Komyakov B.K. Urologiya: uchebnik. 2-e izd., pererab. i dopoln. M.: GEOTAR-Media, 2018. 480 s.
28. Komyakov B.K., Nazarov T.Kh., Rizoev Kh.Kh. Khronicheskii obstruktivnyi prostatit: monografiya. Izd. 2-e, dop. SPb: Russkaya kollektsiya, 2016. 111 s.
29. Nazarov T.N., Mikhailichenko V.V. Effektivnost' primeneniya preparata tadenan pri khronicheskom prostatite, oslozhnennom besplodiem. Urologiya 2008;(4):40–3.
30. Nazarov T.N., Novikov A.I, Mikhailichenko V.V., Rizoev Kh.Kh. i dr. Primenenie dimeksid-fermentnoi smesi v kompleksnoi terapii khronicheskogo bakterial'nogo prostatita u muzhchin s narusheniem fertil'nosti. Andrologiya i genital'naya khirurgiya 2011;4:54–7.
31. Bartoletti R., Cai T., Nesi G. et al. The impact of biofilm-producing bacteria on chronic bacterial prostatitis treatment: results from a longitudinal cohort study. World J Urol 2014;32(3):737–42. DOI: 10.1007/s00345-013-1145-9
32. Koseoglu H., Aslan G., Sen B.H. et al. [Prostatic calculi: silent stones (In Spanish)]. Actas Urol Esp 2010;34(6);555–9. DOI: 10.1016/S2173-5786(10)70129-3
33. Dessombz A., Méria P., Bazin D., Daudon M. Prostatic stones: evidence of a specific chemistry related to infection and presence of bacterial imprints. PLoS One 2012;7(12):e51691. DOI: 10.1371/journal.pone.0051691
34. Tiktinskii O.L., Tiktinskii N.O. Infektsionnyi prostatit i epidemiologiya. Materialy plenuma pravleniya Rossiiskogo obshchestva urologov. M., 2004. S. 369.
35. Tkachuk V.N. Khronicheskii prostatit. M.: Meditsina dlya vsekh, 2006. 112 s.
36. Sutor D.J., Wooley S.E. The crystalline composition of prostatic calculi. Br J Urol 1974;46(5):533–5. DOI: 10.1111/j.1464-410x.1974.tb03852.x
37. Torres Ramirez C., Aguilar Ruiz J., Zuluaga Gomez A. et al. A crystallographic study of prostatic calculi. J Urol 1980;124(6):840–3. DOI: 10.1016/s0022-5347(17)55691-8
38. Cristol D.S., Emmett J.L. The incidence of coincident prostatic calculi, prostatic hyperplasia and carcinoma of the prostate gland. JAMA 1944;124(10):646. DOI: 10.1001/jama.1944.62850100004008a
39. Griffiths G.J., Clements R., Jones D.R. et al. The ultrasound appearances of prostatic cancer with histological correlation. Clin Radiol 1987;38(3):219–27. DOI: 10.1016/s0009-9260(87)80048-x
40. Smolski M., Turo R., Whiteside S. et al. Prevalence of prostatic calcification subtypes and association with prostate cancer. Urology 2015;85(1):178–81. DOI: 10.1016/j.urology.2014.09.026
41. Dell Atti L., Galosi A.B., Ippolito C. Prostatic calculi detected in peripheral zone of the gland during a transrectal ultrasound biopsy can be significant predictors of prostate cancer. Arch Ital Urol Androl 2016;88(4):304–7. DOI: 10.4081/aiua.2016.4.304
42. Kim S.H., Jung K.I., Koh J.S. et al. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi? Urol Int 2013;90(2):144–9. DOI: 10.1159/000342643
43. Harada K., Igari D., Tanahashi Y. Gray scale transrectal ultransonography of the prostate. J Clin Ultrasound 1979;7(1):45–9. DOI: 10.1002/jcu.1870070113
44. Guseinov F.I.O., Kamni predstatel'noi zhelezy u bol'nykh adenomoi i rakom prostaty. Dis. … kand. med. nauk. M., 2013. 123 s.
45. Epstein J.I. Prostate biopsy interpretation, 2nd edn. Philadelphia: Lippincott Raven, 1995. 30 p.
46. Bai Y., Wang M.-Y., Han Y.-H. et al. Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification. PLoS One 2013;8(1):e53237. DOI: 10.1371/journal.pone.0053237
47. Sfanos K.S., Wilson B.A., De Marzo A.M., Isaacs W.B. Acute inflammatory proteins constitute the organic matrix of prostatic corpora amylacea and calculi in men with prostate cancer. Proc Natl Acad Sci U S A 2009;106(9):3443–8. DOI: 10.1073/pnas.0810473106
48. Yanamandra K., Alexeyev O., Zamotin V. et al. Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS One 2009;4(5):e5562. DoI: 10.1371/journal. pone.0005562
49. Horita S., Nitta K., Ozasa H. et al. Localization of beta-2-microglobulin in prostatic corpora amylacea of prostatic hypertrophy patients. Nephron 1996;72(4):730–1. DOI: 10.1159/000188981
50. Vilches J., Lopez A., De Palacio L. et al. SEM and X-ray microanalysis of human prostatic calculi. J Urol 1982;127(2):371–3. DOI: 1016/s0022-5347(17)53784-2
51. Najoui M., Qarro A., Ammani A., Alami M. Giant prostatic calculi. Pan Afr Med J 2013;14:69. DOI: 10.11604/pamj.2013.14.69.2376
52. Kapogiannis F., Fasoulakis K., Fragkoulis C. et al. Total osseous calcification of the prostate gland. Cureus 2020;12(7):e9239. DOI: 10.7759/cureus.9239
53. Zhao W.P., Li Y.T., Chen J. et al. Prostatic calculi influence the antimicrobial efficacy in men with chronic bacterial prostatitis. Asian J Androl 2012;14(5):715–9. DOI: 10.1038/aja.2012.40
54. Cha W.H., Kim K.H., Seo Y.J. The effect of periurethral prostatic calculi on lower urinary tract symptoms in benign prostatic hyperplasia. Korean J Urol 2008;49(3):237–41. DOI: 10.4111/kju.2008.49.3.237
55. Shoskes D.A., Lee C.T., Murphy D. et al. Incidence and significance of prostatic stones in men with chronic prostatitis/chronic pelvic pain syndrome. Urology 2007;70(2):235–8. DOI: 10.1016/j.urology.2007.04.008
56. Trinchieri A., Perletti G., Magri V. Prostatic calcifications and symptoms of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol Suppl 2010;9:137–8.
57. Kuei C.H., Liao C.H., Chiang B.J. Significant intravesical prostatic protrusion and prostatic calcification predict unfavorable outcomes of medical treatment for male lower urinary tract symptoms. Urol Sci 2016;27(1):13–6. DOI: 10.1016/j.urols.2015.01.003
58. Jeon H.J., Chung H.C., Song J.M. Effects of residual prostatic calculi on lower urinary tract symptoms after transurethral resection of prostate. Korean J Urol 2005;46:569–73.
